文献速递糖尿病

流感疫苗接种与糖尿病患者心血管死亡率降低相关:一项全国性队列研究

Influenza Vaccination Is Associated With Reduced Cardiovascular Mortality in Adults With Diabetes: A Nationwide Cohort Study.
PubMed 文献 · Diabetes Care · 2020-07-09

该研究利用丹麦全国登记数据,纳入241,551例糖尿病患者,在2007-2016年连续九个流感季节中评估流感疫苗接种与心血管结局的关联。经混杂因素调整后,接种疫苗与全因死亡(HR 0.83)、心血管死亡(HR 0.84)及急性心肌梗死或卒中死亡(HR 0.85)风险降低显著相关。作者认为流感疫苗接种可能改善糖尿病患者结局。

要点

  • 在糖尿病患者中,流感疫苗接种与全因死亡风险降低相关(HR 0.83,P<0.001)。
  • 流感疫苗接种与心血管死亡风险降低相关(HR 0.84,P<0.001)。
  • 流感疫苗接种与急性心肌梗死或卒中死亡风险降低相关(HR 0.85,P=0.028)。

核心结论

  • 在糖尿病患者中,流感疫苗接种与全因死亡、心血管死亡及急性心肌梗死或卒中死亡风险降低相关;作者认为流感疫苗接种可能改善糖尿病患者结局。

研究设计与样本

  • 研究使用丹麦全国登记数据,纳入2007-2016年连续九个流感季节的糖尿病患者;糖尿病定义为使用降糖药物。
  • 排除年龄不在18-100岁或患有缺血性心脏病、心力衰竭、慢性阻塞性肺疾病、癌症或脑血管疾病的患者。
  • 共241,551例患者被监测,中位随访四个季节(四分位距二至八季),总随访425,318人年。
  • 每个季节从12月1日监测至次年4月1日。

主要发现

  • 研究季节期间疫苗覆盖率范围为24%至36%。
  • 随访期间,全因死亡8,207例(3.4%),心血管死亡4,127例(1.7%),急性心肌梗死或卒中死亡1,439例(0.6%)。
  • 调整混杂因素后,接种疫苗与全因死亡风险降低显著相关(HR 0.83,P<0.001)。
  • 调整混杂因素后,接种疫苗与心血管死亡风险降低显著相关(HR 0.84,P<0.001)。
  • 调整混杂因素后,接种疫苗与急性心肌梗死或卒中死亡风险降低显著相关(HR 0.85,P=0.028),并与因糖尿病相关急性并发症(糖尿病酮症酸中毒、低血糖或昏迷)住院风险降低相关(HR 0.89,P=0.006)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Recent influenza infection is associated with an increased risk of atherothrombotic events, including acute myocardial infarction (AMI) and stroke. Little is known about the association between influenza vaccination and cardiovascular outcomes in patients with diabetes. RESEARCH DESIGN AND METHODS: We used nationwide register data to identify patients with diabetes in Denmark during nine consecutive influenza seasons in the period 2007-2016. Diabetes was defined as use of glucose-lowering medication. Patients who were not 18-100 years old or had ischemic heart disease, heart failure, chronic obstructive lung disease, cancer, or cerebrovascular disease were excluded. Patient exposure to influenza vaccination was assessed before each influenza season. We considered the outcomes of death from all causes, death from cardiovascular causes, and death from AMI or stroke. For each season, patients were monitored from December 1 until April 1 the next year. RESULTS: A total of 241,551 patients were monitored for a median of four seasons (interquartile range two to eight seasons) for a total follow-up of 425,318 person-years. The vaccine coverage during study seasons ranged from 24% to 36%. During follow-up, 8,207 patients died of all causes (3.4%), 4,127 patients died of cardiovascular causes (1.7%), and 1,439 patients died of AMI/stroke (0.6%). After adjustment for confounders, vaccination was significantly associated with reduced risks of all-cause death (hazard ratio [HR] 0.83, P < 0.001), cardiovascular death (HR 0.84, P < 0.001), and death from AMI or stroke (HR 0.85, P = 0.028) and a reduced risk of being admitted to hospital with acute complications associated with diabetes (diabetic ketoacidosis, hypoglycemia, or coma) (HR 0.89, P = 0.006). CONCLUSIONS: In patients with diabetes, influenza vaccination was associated with a reduced risk of all-cause death, cardiovascular death, and death from AMI or stroke. Influenza vaccination may improve outcome in patients with diabetes.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Modin D, Claggett B, Køber L, et al. Influenza Vaccination Is Associated With Reduced Cardiovascular Mortality in Adults With Diabetes: A Nationwide Cohort Study. Diabetes Care. 2020. PMID: 32647052. doi:10.2337/dc20-0229

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。